No single test determines suitability. Clinicians combine donor history, physical findings, electrocardiography, echocardiography, hemodynamic measurements, laboratory results, and selected coronary angiography to judge structure, contractility, perfusion, injury, and transmissible risks. This integrated approach helps distinguish an isolated abnormality from a broader pattern that could affect post-transplant cardiac function.
Echocardiography provides information about cardiac structure and contractility, while hemodynamic data contribute measurements related to cardiovascular performance. Considering both forms of evidence gives the transplant team a more complete view than either assessment alone. Their combined interpretation supports estimation of whether the graft is likely to function safely and helps identify concerns requiring further review.
A finding that appears concerning may not automatically exclude a donor heart if it represents a reversible abnormality. The assessment therefore distinguishes abnormalities that may be addressed or interpreted in context from findings that create a contraindication. This distinction can prevent premature rejection of usable organs while maintaining attention to recipient safety and the likelihood of primary graft dysfunction.
The evaluation supplies clinical information needed to compare the donor heart with the circumstances of a potential recipient. Teams use the overall cardiac findings, laboratory information, and identified risks to support donor-recipient matching and organ allocation. This process helps balance the expected safety and function of the graft against the urgency and clinical needs of transplantation.
The process begins with donor history and physical findings, followed by cardiac testing that includes electrocardiography, echocardiography, and hemodynamic evaluation. Laboratory tests add information about injury and transmissible risks. When indicated, coronary angiography contributes additional perfusion information. The team then integrates these results to identify contraindications, recognize reversible abnormalities, and make a timely allocation decision.
Coronary angiography is performed when indicated rather than as an automatic component of every evaluation. Its role is to add information about coronary perfusion to the findings from history, examination, electrocardiography, echocardiography, hemodynamics, and laboratory testing. That additional evidence can refine judgments about injury, suitability, and the expected function of the transplanted heart.